Global perspectives on immunization against SARS-CoV-2 during pregnancy and priorities for future research: an international consensus paper from the World Association of Infectious Diseases and Immunological Disorders
posted on 2023-05-21, 10:07authored byAbu-Raya, B, Madhi, SA, Omer, SB, Amirthalingam, G, Giles, ML, Katie FlanaganKatie Flanagan, Zimmermann, P, O'Ryan, M, Safadi, MA, Papaevangelou, V, Maertens, K, Wanlapakorn, N, Diaz-Brito, V, Tommelein, E, Esposito, S
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.